Noteworthy Read
The Hemp Didn’t Get Killed by Regulators — It Killed Itself (Marijuana Moment)
This op-ed argues that the hemp industry’s struggles are largely self-inflicted, pointing to inconsistent product quality, lack of standards, and a rush toward intoxicating derivatives as key factors that eroded trust and invited regulatory scrutiny.
Read the article
View more in CBD
More Noteworthy Reading
The rise of minor cannabinoids: THCV and CBN the next big trends (Rolling Stone)
As the cannabis landscape evolves, attention is shifting toward lesser-known compounds like THCV and CBN, which are gaining interest for their unique effects on energy, appetite, and sleep. The trend reflects a move beyond THC toward more targeted, functional cannabis experiences.
Pesticide Contamination in Commercial Cannabis (Beyond Pesticides)
An investigation highlights ongoing concerns around pesticide use in cannabis cultivation, pointing to gaps in regulation and testing that can leave consumers exposed to harmful residues. The findings emphasize the need for cleaner growing practices and stronger oversight.
Trippy Tobacco: Plants Engineered to Create Five Psychedelics at Once (Science)
Scientists have successfully engineered tobacco plants to produce multiple psychedelic compounds simultaneously, potentially opening new possibilities for scalable production and research while raising questions about regulation and access.
Read more
View more in Psychedelics
The Surprising Ways Cannabis May Affect the Aging Brain (Washington Post)
Emerging research suggests cannabis may influence the aging brain in complex ways, potentially supporting some aspects of cognitive function while also carrying risks depending on dose, frequency, and individual health.
Read more
View more in Endocannabinoid System
Research Round-Up
Psychedelics for Cancer Pain Management (ScienceDirect)
A growing body of research is exploring how psychedelics may help people manage chronic cancer-related pain, not only by altering pain perception but also by shifting emotional and psychological responses to suffering.
Read more
View more in Psychedelics
Psychedelic Therapy and Traditional Antidepressants Show Similar Results (PsyPost)
A new study found that psychedelic-assisted therapy and conventional antidepressants produced comparable improvements in depression under certain conditions, suggesting both approaches may offer benefits depending on the individual and context.
Read more
View more in Psychedelics
A heartfelt thank you to all of the CBD brands whose generous support allows Project CBD to shine a light on the plant medicine research and stories that matter most to our community.
The post Project CBD Newsletter: Examining the hemp industry’s self-inflicted struggles, minor cannabinoids in the limelight, psychedelics for cancer pain, and more appeared first on Project CBD.